Inventor mobility and the geography of knowledge flows: evidence from the US biopharmaceutical industry

2017 ◽  
pp. scx001 ◽  
Author(s):  
Zafer Sonmez
Keyword(s):  
Knowledge Flows ◽  
Biopharmaceutical Industry ◽  
The Us

Flow Signals: Evidence from Patent and Alliance Portfolios in the US Biopharmaceutical Industry

2017 ◽  
Vol 55 (2) ◽  
pp. 232-264 ◽  
Author(s):  
Turanay Caner ◽  
Olga Bruyaka ◽  
John E. Prescott
Keyword(s):  
Biopharmaceutical Industry ◽  
The Us ◽  
Alliance Portfolios

THE EFFECTS OF ALLIANCE PORTFOLIO DIVERSITY ON INNOVATION PERFORMANCE: A STUDY OF PARTNER AND ALLIANCE CHARACTERISTICS IN THE BIO-PHARMACEUTICAL INDUSTRY

2017 ◽  
Vol 21 (01) ◽  
pp. 1750001 ◽  
Author(s):  
KLAUS MARHOLD ◽  
MARCO JINHWAN KIM ◽  
JINA KANG
Keyword(s):  
Pharmaceutical Industry ◽  
Innovation Performance ◽  
Biopharmaceutical Industry ◽  
Negative Interaction ◽  
Alliance Portfolio ◽  
The Us ◽  
Partner Characteristics ◽  
Two Measures ◽  
Alliance Partners ◽  
Diversity Research

This study investigates the effects of alliance portfolio diversity on the innovation performance of firms. Alliance portfolio diversity is defined using partner characteristics (partner industrial background) and alliance characteristics (alliance objective). We also investigate the interaction between these two measures of diversity on innovation performance. The hypotheses are tested on a dataset of R&D alliances in the US biopharmaceutical industry from 1998–2002. We find an inverted U-shape relationship between the diversity of alliance partners’ industrial background and innovation performance, and a negative interaction of partner diversity and the diversity of the alliance objectives. This study contributes to the growing field of alliance portfolio diversity research by introducing a new alliance characteristic-based dimension of diversity and testing the interaction of different diversities. Our findings imply that firms with diverse alliance partners in particular need to be careful not to focus on too many objectives at the same time.

EMNC technological knowledge flow patterns: an overview of the US patents granted

2019 ◽  
Vol 28 (1) ◽  
pp. 129-155
Author(s):  
Feng Zhang
Keyword(s):  
Flow Patterns ◽  
Technological Knowledge ◽  
Knowledge Flows ◽  
Knowledge Generation ◽  
Knowledge Flow ◽  
Industrialized Countries ◽  
Content Type ◽  
Technological Competence ◽  
The Us ◽  
Internal Knowledge

Purpose With considerable attention paid to the motives and process of idiosyncratic internationalization trajectory of multinationals from emerging economies (EMNCs), little is known on whether, and if so how, new competitive advantages of EMNCs are created and accumulated over time. MNC and EMNC literature agrees on the importance of external and internal knowledge linkages in technological competence creation. By building upon this framework, this paper aims to evaluate EMNCs’ external and internal knowledge flow patterns by benchmarking their counterparts from mature industrialized countries (MMNCs). Design/methodology/approach This study analyzes US patents granted between 2000 and 2014 to leading innovation-oriented EMNCs from China and India, and their matched MMNCs. Being the first to use the US patent and citation data in studying leading innovation-oriented EMNCs, the authors use a descriptive statistical method. Findings The findings offer empirical insights of the scale, scope and quality of EMNC technological competence creation. Moreover, in contrast to existing EMNC literature, it is found that EMNC parents have been the most important center of EMNC technological knowledge generation. The matched group comparisons of external and internal knowledge flows further reveal detailed similarities and differences of competence creation between EMNCs and MMNCs, and among EMNCs. Originality/value This study represents one of the first attempts to investigate the post-internationalization technological competence creation of EMNCs by using a novel data source. This study sets the foundation to deepen the understanding of EMNC technological competence creation. The findings suggest interesting propositions and offer important implications for future researches.

scholarly journals Biopharmaceutical Industry Capability Building in India: Report from a Symposium

2021 ◽  
Author(s):  
Annu Uppal ◽  
Ranjan Chakrabarti ◽  
Narendra Chirmule ◽  
Anurag Rathore ◽  
Fouad Atouf
Keyword(s):  
Control Strategies ◽  
Biopharmaceutical Industry ◽  
Gene Therapies ◽  
Governmental Agencies ◽  
Global Standards ◽  
Advanced Manufacturing Technologies ◽  
The Us ◽  
Capability Building ◽  
Manufacturing Technologies ◽  
And Control

AbstractThe biopharmaceutical industry is evolving with a shift in focus from recombinant proteins and antibodies towards more complex cell and gene therapies. To be competitive globally, biomanufacturers need to focus on aligning with global standards with regard to drug quality, reducing manufacturing failures and delivering drugs to market quickly. Building these capabilities requires a multifaceted approach that includes improvements in operations, quality compliance, and control strategies. To address these needs, the US Pharmacopeia (USP), the Department of Biotechnology (DBT) India, and the Confederation of Indian Industry (CII) held a symposium to discuss the requirements and gaps in the biotechnology and pharmaceutical sectors in India and other developing countries. A panel of experts from academia, manufacturing, and governmental agencies identified several drivers needed for capability building, including a skilled workforce, public–private partnerships, advanced manufacturing technologies, novel biologics, and favorable policies. This article summarizes the recommendations put forward by this panel.

Putting the cart (antecedents) before the horse (absorptive capacity): the role of competitive antecedents to the absorptive capacity innovation process

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Desmond Ng ◽  
Leonardo F. Sanchez-Aragon
Keyword(s):  
Absorptive Capacity ◽  
Negative Binomial ◽  
Innovation Process ◽  
Positive Influence ◽  
Knowledge Flows ◽  
Relative Advantage ◽  
Estimation Methods ◽  
Content Type ◽  
External Knowledge ◽  
The Us

Purpose The purpose of this study is to theoretically and empirically advance a concept of competitive antecedents to absorptive capacity (AC) research and to explain their relationship to a firm’s innovative performance. A firm’s competitive antecedents involve a relative advantage in a firm’s ability to access external knowledge – (i.e. relative advantage in external knowledge flows) – and a relative advantage in appropriating these external knowledge flows (i.e. relative advantage in appropriability regime). Design/methodology/approach By drawing on network and market share explanations, hypotheses were developed in which a firm’s AC is argued to mediate the influence of these competitive antecedents on a firm’s innovations. In using linear and negative binomial estimation methods, a mediation analysis of the US biotechnology industry was conducted. Findings A firm’s competitive antecedents have a positive influence on a firm’s AC and that these influences indirectly impact a biotechnology firm’s product innovations. Originality/value While a firm’s innovation is widely attributed to its AC, this study’s concept of competitive antecedents shows that a firm’s competitive advantage lies upstream from its AC.

Sign in / Sign up

Export Citation Format

Share Document